{"news_desk": "National", "print_page": "20", "section_name": "U.S.", "subsection_name": null, "byline": {"contributor": "", "original": "By SABRINA TAVERNISE", "person": [{"rank": 1, "role": "reported", "firstname": "Sabrina", "organization": "", "lastname": "TAVERNISE"}]}, "abstract": "Food and Drug Administration approves Narcan nasal spray, created by Adapt Pharma Incto to reverse opioid overdoses; approval expands options for treating overdoses without medical training.", "type_of_material": "Brief", "word_count": "87", "lead_paragraph": "A nasal spray designed to reverse opioid overdoses won approval from the Food and Drug Administration, expanding the options for treating drug overdoses without medical training.", "pub_date": "2015-11-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Approves a Nasal Spray to Combat Opioid Overdose", "content_kicker": "National Briefing | Health", "print_headline": "F.D.A. Approves a Nasal Spray to Combat Opioid Overdose"}, "snippet": "A nasal spray designed to reverse opioid overdoses won approval from the Food and Drug Administration, expanding the options for treating drug overdoses without medical training.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/11/19/us/fda-approves-a-nasal-spray-to-combat-opioid-overdose.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drug Abuse and Traffic", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Naloxone (Drug)", "name": "subject"}], "blog": [], "_id": "564d433638f0d81eb3ced0d7", "source": "The New York Times"}